Annual Cash & Cash Equivalents
$95.90 M
+$19.20 M+25.03%
December 31, 2023
Summary
- As of February 7, 2025, NGVT annual cash & cash equivalents is $95.90 million, with the most recent change of +$19.20 million (+25.03%) on December 31, 2023.
- During the last 3 years, NGVT annual cash & cash equivalents has fallen by -$161.80 million (-62.79%).
- NGVT annual cash & cash equivalents is now -65.18% below its all-time high of $275.40 million, reached on December 31, 2021.
Performance
NGVT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$135.50 M
+$28.10 M+26.16%
September 30, 2024
Summary
- As of February 7, 2025, NGVT quarterly cash and cash equivalents is $135.50 million, with the most recent change of +$28.10 million (+26.16%) on September 30, 2024.
- Over the past year, NGVT quarterly cash and cash equivalents has increased by +$28.10 million (+26.16%).
- NGVT quarterly cash and cash equivalents is now -55.24% below its all-time high of $302.70 million, reached on March 31, 2020.
Performance
NGVT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NGVT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.0% | +26.2% |
| 3 y3 years | -62.8% | -49.7% |
| 5 y5 years | +23.7% | +79.2% |
NGVT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.2% | +25.0% | -50.8% | +99.3% |
| 5 y | 5-year | -65.2% | +69.7% | -55.2% | +139.8% |
| alltime | all time | -65.2% | +699.2% | -55.2% | +803.3% |
Ingevity Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $135.50 M(+26.2%) |
| Jun 2024 | - | $107.40 M(+21.4%) |
| Mar 2024 | - | $88.50 M(-7.7%) |
| Dec 2023 | $95.90 M(+25.0%) | $95.90 M(+13.5%) |
| Sep 2023 | - | $84.50 M(+24.3%) |
| Jun 2023 | - | $68.00 M(-12.7%) |
| Mar 2023 | - | $77.90 M(+1.6%) |
| Dec 2022 | $76.70 M(-72.1%) | $76.70 M(+6.1%) |
| Sep 2022 | - | $72.30 M(-44.9%) |
| Jun 2022 | - | $131.30 M(-41.0%) |
| Mar 2022 | - | $222.60 M(-19.2%) |
| Dec 2021 | $275.40 M(+6.9%) | $275.40 M(+2.2%) |
| Sep 2021 | - | $269.40 M(+15.5%) |
| Jun 2021 | - | $233.30 M(-1.9%) |
| Mar 2021 | - | $237.80 M(-7.7%) |
| Dec 2020 | $257.70 M(+356.1%) | $257.70 M(+30.0%) |
| Sep 2020 | - | $198.20 M(+11.6%) |
| Jun 2020 | - | $177.60 M(-41.3%) |
| Mar 2020 | - | $302.70 M(+435.8%) |
| Dec 2019 | $56.50 M | $56.50 M(-25.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $75.60 M(+41.8%) |
| Jun 2019 | - | $53.30 M(+38.8%) |
| Mar 2019 | - | $38.40 M(-50.5%) |
| Dec 2018 | $77.50 M(-11.8%) | $77.50 M(+34.8%) |
| Sep 2018 | - | $57.50 M(-30.7%) |
| Jun 2018 | - | $83.00 M(+50.9%) |
| Mar 2018 | - | $55.00 M(-37.4%) |
| Dec 2017 | $87.90 M(+188.2%) | $87.90 M(+25.2%) |
| Sep 2017 | - | $70.20 M(+72.9%) |
| Jun 2017 | - | $40.60 M(+36.7%) |
| Mar 2017 | - | $29.70 M(-2.6%) |
| Dec 2016 | $30.50 M(-4.7%) | $30.50 M(+12.5%) |
| Sep 2016 | - | $27.10 M(-51.3%) |
| Jun 2016 | - | $55.70 M(+145.4%) |
| Mar 2016 | - | $22.70 M(-29.1%) |
| Dec 2015 | $32.00 M(+60.0%) | $32.00 M(+6.7%) |
| Sep 2015 | - | $30.00 M(+100.0%) |
| Jun 2015 | - | $15.00 M(-25.0%) |
| Dec 2014 | $20.00 M(+66.7%) | $20.00 M |
| Dec 2013 | $12.00 M | - |
FAQ
- What is Ingevity annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ingevity?
- What is Ingevity annual cash & cash equivalents year-on-year change?
- What is Ingevity quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Ingevity?
- What is Ingevity quarterly cash and cash equivalents year-on-year change?
What is Ingevity annual cash & cash equivalents?
The current annual cash & cash equivalents of NGVT is $95.90 M
What is the all time high annual cash & cash equivalents for Ingevity?
Ingevity all-time high annual cash & cash equivalents is $275.40 M
What is Ingevity annual cash & cash equivalents year-on-year change?
Over the past year, NGVT annual cash & cash equivalents has changed by +$19.20 M (+25.03%)
What is Ingevity quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NGVT is $135.50 M
What is the all time high quarterly cash and cash equivalents for Ingevity?
Ingevity all-time high quarterly cash and cash equivalents is $302.70 M
What is Ingevity quarterly cash and cash equivalents year-on-year change?
Over the past year, NGVT quarterly cash and cash equivalents has changed by +$28.10 M (+26.16%)